金德尔摩根美股招股说明书(2026-07-29版)

$1,150,000,000 5.550% Senior Notes due 2036$600,000,000 6.150% Senior Notes due 2056 Interest on the 5.550% senior notes due 2036 (the “notes due 2036”) is payable semi-annually in arrears on February1 andAugust1 of each year, beginning on February1, 2027, and the notes due 2036 will mature on August 1, 2036. Interest on the6.150% senior notes due 2056 (the “notes due 2056” and, together with the notes due 2036, the “notes”) is payable semi-annually in arrears on February 1 and August 1 of each year, beginning on February 1, 2027, and the notes due 2056 will matureon August 1, 2056. We may redeem all or a part of the notes of either series at any time at the applicable redemption pricedescribed under “Description of Notes — Optional Redemption.” The notes will be unconditionally guaranteed, jointly and severally, by substantially all of our wholly owned subsidiariespursuant to a cross guarantee agreement among us and such subsidiaries. The notes rank equally in right of payment with ourother unsecured and unsubordinated indebtedness from time to time outstanding. The guarantees represent unsecured andunsubordinated indebtedness of each subsidiary guarantor and rank equally in right of payment to such subsidiary guarantor’sother unsecured and unsubordinated indebtedness from time to time outstanding. Investing in the notes involves risks. Please see “Risk Factors” on pageS-4for more information regarding risks you shouldconsider before investing in the notes. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesesecurities or passed upon the adequacy or accuracy of this prospectus supplement and the accompanying prospectus to which itrelates. Any representation to the contrary is a criminal offense. (1)Plus accrued and unpaid interest, if any, from August 6, 2026 if settlement occurs after that date. Each series of notes constitutes a new issue of securities with no established trading market. We do not intend to apply forlisting of the notes of either series on any securities exchange. This prospectus supplement and the accompanying prospectus are not intended to constitute an offer to, and the notesshould not be purchased, held or otherwise acquired by, a “specified foreign entity” as defined in Section7701(a)(51)(B) of theInternal Revenue Code of 1986, as amended (an “SFE”). By purchasing the notes, any investor in the notes (including allaffiliated entities that participate in such purchase) will be deemed to represent and warrant to us that it is not, and will not be,for its taxable year that includes the date of the original issuance of the notes, an SFE. The underwriters expect that delivery of the notes will be made to investors in book-entry form through the facilities of TheDepository Trust Company, including Clearstream Banking, S.A. and/or Euroclear Bank SA/NV, on August6, 2026 againstpayment in New York, New York. BofASecurities Securities The date of this prospectus supplement is July 28, 2026. This document is in two parts. The first part is the prospectus supplement, which provides a briefdescription of our business and the specific terms of this offering. The second part, the accompanyingprospectus dated October20, 2023, gives more general information, some of which may not apply to thisoffering. If the description of this offering varies between this prospectus supplement and the accompanyingprospectus, you should rely on the information in this prospectus supplement. You should rely only on the information contained or incorporated by reference in this prospectussupplement, the accompanying prospectus, any related free writing prospectus prepared by us or on ourbehalf or any other information to which we have referred you. Neither we nor the underwriters haveauthorized anyone to provide you with different information. This prospectus supplement and theaccompanying prospectus may only be used where it is legal to offer or sell the offered securities. Youshould not assume that the information in this prospectus supplement, the accompanying prospectus or anyrelated free writing prospectus is accurate as of any date other than the respective date on the front cover ofthose documents. You should not assume that the information incorporated by reference in this prospectussupplement and the accompanying prospectus is accurate as of any date other than the date the respectiveinformation was filed with the Securities and Exchange Commission (the “SEC”). Our business, financialcondition, results of operations and prospects may have changed since those dates. TABLE OF CONTENTS Prospectus Supplement SummaryS-1Risk FactorsS-4Use of ProceedsS-5CapitalizationS-6Description of NotesS-7Material U.S. Federal Income Tax ConsequencesS-11UnderwritingS-16Validity of the NotesS-24ExpertsS-24ProspectusAbout This Prospectus1Where You Can Find More Information1Kinder Morgan, Inc.2Risk Factors2Cautionary Statement Regarding Forward-Look